| http://www.w3.org/ns/prov#value | - mically modified tetracyclines (known to have inhibitory effects on inflammatory mediators and effector molecules, including cytokines and matrix metalloproteinases) on improving PD and ASVD biomarkers in patients who exhibit both diseases15.
|
